This project will examine several genetic and immunologic parameters in human corneal transplant recipients to explore possible correlations with allograft rejection. Specifically, patients at high risk for rejection because of corneal vascularization or prior graft loss will receive only ABO blood group, donor-lymphocyte crossmatch negative grafts with the benefit of prospective HLA-A,-B,-C and -DR matching evaluated. Both high- and low-risk patients will be screened prior to grafting for the persence of antibodies to histocompatibility antigens, lymphocyte differentiation markers, vascular endothelium antigens, and corneal tissue antigens. Similar evaluation will be performed post-transplant and during rejection episodes. Donor-specific reactivity will be assessed by utilizing an annulus of donor cornea for indirect immunofluorescence with recipient serum. Detection and characterization of antibodies will be made using both sensitive microcytotoxicity and antigen binding assays to determine whether certain functional characteristics may correlate with rejection. Host cellular immunity will also be examined using lymphocyte mediated cytotoxicity against human lymphocytes, corneal cells and vascular endothelium. Both fresh and cultured human corneal endothelial cells will be examined for the expression of various antigens using a variety of serologic assays. Monoclonal, as well as isologous and heterologous serum reagents with specificity for HLA antigens, lymphocyte differentiation antigens, and vascular endothelium/monocyte antigens, will be used to characterize such corneal endothelial markers. These studies are proposed to: 1) determine if prospective HLA-A,-B,-C and -DR donor-recipient matching is of benefit in crossmatch negative high-risk corneal allograft patients; 2) determine if any detectable serologic or cellular parameter of immunity is of diagnostic or prognostic value in predicting eventual graft rejection; 3) determine the antigenic nature of the corneal endothelium which is an important target for immune mediated graft rejection.
| Marsh-Armstrong, N; McCaffery, P; Gilbert, W et al. (1994) Retinoic acid is necessary for development of the ventral retina in zebrafish. Proc Natl Acad Sci U S A 91:7286-90 |
| Howell, D N; Ross, J R; Miller, S E et al. (1994) Characterization of a novel family of ciliary body glycoproteins. Invest Ophthalmol Vis Sci 35:3308-18 |
| McCaffrery, P; Posch, K C; Napoli, J L et al. (1993) Changing patterns of the retinoic acid system in the developing retina. Dev Biol 158:390-9 |
| McCaffery, P; Drager, U C (1993) Retinoic acid synthesis in the developing retina. Adv Exp Med Biol 328:181-90 |
| McCaffery, P; Lee, M O; Wagner, M A et al. (1992) Asymmetrical retinoic acid synthesis in the dorsoventral axis of the retina. Development 115:371-82 |
| Howell, D N; Burchette Jr, J L; Paolini, J F et al. (1991) Characterization of a novel human corneal endothelial antigen. Invest Ophthalmol Vis Sci 32:2473-82 |
| McCaffery, P; Tempst, P; Lara, G et al. (1991) Aldehyde dehydrogenase is a positional marker in the retina. Development 112:693-702 |
| Sanfilippo, F; Foulks, G N (1989) The role of histocompatibility in human corneal transplantation. Transplant Proc 21:3127-9 |
| Ruiz, P; Foulks, G N; Sanfilippo, F (1989) Donor-specific cytotoxic T-cell alloreactivity in successfully engrafted high-risk cornea patients. Transplant Proc 21:3153-5 |
| Sanfilippo, F; MacQueen, J M; Vaughn, W K et al. (1986) Reduced graft rejection with good HLA-A and B matching in high-risk corneal transplantation. N Engl J Med 315:29-35 |
Showing the most recent 10 out of 11 publications
